Wednesday, November 19, 2025 Abstract IND.227 oral presentation at the World Conference on Lung Cancer in Barcelona, Spain, on 8 September, 2025. Subsequently published in the Journal of Thoracic Oncology. The updated analysis now incorporates additional patients enrolled to the phase 2 component of the trial originally excluded from the OS analysis. Laurie S, Chu Q, Perrone F, Greillier L, Tu W, Piccirillo MC, Grosso F, Lo Russo G, Florescu M, Mencoboni M, Morabito A, Cecere FL, Ceresoli GL, Dawe DE, Zucali PA, Pagano M, Goffin JR, Sanchez ML, Gridelli C, Zalcman G, Quantin X, Westeel V, Gargiulo P, Delfanti S, Tu D, Lee CW, Leighl N, Sederias J, Brown-Walker P, Luo Y, Lantuejoul S, Tsao MS, Scherpereel A, Bradbury P, Seymour L. OA12.02 CCTG IND227, a Randomized Trial of Chemotherapy + Pembrolizumab in Advanced Pleural Mesothelioma: Updated Analyses. World Conference on Lung Cancer. Journal of Thoracic Oncology 20 [10], S36. 2025. https://doi.org/10.1016/j.jtho.2025.09.070
